# Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study

> No summary available.

## Metadata
- Authors: Matthias B. Moor, Franziska Suter‐Riniker, Michael P. Horn, Daniel Aeberli, Jennifer Amsler, Burkhard Möller, Linet Njue, Cesare Medri, Anne Angelillo‐Scherrer, Luca Borradori, Susanne Radonjic‐Hoesli, S. Morteza Seyed Jafari, Andrew Chan, Robert Hoepner, Ulrike Bacher, Laila‐Yasmin Mani, Joseena Iype, Cédric Hirzel, Britta Maurer, Daniel Sidler
- Journal: The Lancet Rheumatology
- Published: 2021-09-07
- DOI: https://doi.org/10.1016/s2665-9913(21)00251-4
- Citations: 211
- Source: OpenAlex
- Access: Open Access

## Technology Hub
- Hub: mRNA Therapies
- Discipline: Medicine / Biotechnology
- Hub URL: https://science-database.com/technology/mrna-therapies
- Hub llms.txt: https://science-database.com/technology/mrna-therapies/llms.txt

## Links
- DOI: https://doi.org/10.1016/s2665-9913(21)00251-4
- OpenAlex: https://openalex.org/W3197504359
- PDF: http://www.thelancet.com/article/S2665991321002514/pdf
- JSON API: https://science-database.com/api/v1/technology/mrna-therapies

---
Generated by science-database.com — The Knowledge Interface
Paper ID: oa-W3197504359 | Hub: mrna-therapies